Table 2.
Study | Year | Sample size | Mean followup (months) | Rate of medical complications | Mortality rate related to surgery or infection | Annualized reinfection rate | Overall reinfection rate | Failure rates for other reasons | Overall infection eradication success rate |
---|---|---|---|---|---|---|---|---|---|
Azzam et al. [4] | 2010 | 51 | 68 | 25%† | 3% | 11.6% | 66% | NM | 44% |
Odum et al. [72] | 2011 | 53 | NM | NM | 8% | 69%* | 69% | NM | 31% |
Byren et al. [23] | 2009 | 52 | 27 | NM | NM | 11% | 18% | NM | 82% |
Lora-Tamayo et al. [63] | 2013 | 146 | NM | NM | 7% | 38.5%* | 45% | NM | 55% |
Cobo et al. [30] | 2011 | 69 | 24 | NM | 3.6% | 21.5% | 43% | NM | 57% |
Buller et al. [21] | 2012 | 62 | 34 | NM | NM | 40.6%* | 48.2% | NM | 52% |
Koyonos et al. [54] | 2011 | 60 | 54 | NM | NM | 14.5% | 65% | NM | 35% |
El Helou et al. [37] | 2010 | 40 | 24 | NM | 12.5% | 32% | 32% | NM | 68% |
Tornero et al. [92] | 2012 | 39 | 46 | NM | NM | 6.3% | 24% | NM | 76% |
Romano et al. [85] | 2014 | 796 | 48 | NM | NM | 44.9%* | 55% | NM | 45% |
Crockarell et al. [31] | 1998 | 42 | 76 | 11.9% | 7% | 28%* | 79% | 4.7% | 21% |
Brandt et al. [19] | 1997 | 30 | 48 | NM | NM | 54%* | 69% | NM | 31% |
Meehan et al. [68] | 2003 | 19 | 34 | NM | NM | 11%* | 11% | NM | 89% |
Totals | 1459 | 42.8 | 24.7% | 56.7% | 4.7% | 43.3% |
Weighted annual reinfection rate 30.1%; * rate stated explicitly in study; †packed red blood cell transfusion rate; NM = not mentioned.